Intended for healthcare professionals

Research Article

Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.

Br Med J (Clin Res Ed) 1987; 294 doi: (Published 17 January 1987) Cite this as: Br Med J (Clin Res Ed) 1987;294:147
  1. A C Rossi,
  2. J P Hsu,
  3. G A Faich


    Previous reports have suggested that piroxicam may be more ulcerogenic than other non-steroidal anti-inflammatory drugs (NSAIDs) in use. Critics have attributed this putative relation to flawed comparisons of spontaneously reported data. In this study cases of upper gastrointestinal bleeding, perforation, and ulcer reported to the Food and Drug Administration's spontaneous reporting system over 12 years were examined. Reporting rates for eight NSAIDs were compared over identical periods of their marketing life cycles. After adjustments were made for the heterogeneity in the underlying reporting rates the difference in rates between piroxicam and the other drugs was considerably reduced but piroxicam retained its top ranking among the drugs; however, large and clinically important differences in the frequency of cases of upper gastrointestinal bleeding, perforation, and ulcer between piroxicam and the rest of the NSAIDs compared probably do not exist.